
Jiangsu Hengrui Medicine Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Jiangsu Hengrui Medicine
Access all reports
Jiangsu Hengrui Medicine Co., Ltd. is a China-based pharmaceutical company engaged in the research, development, production, and distribution of innovative medicines. The company focuses on therapeutic areas such as oncology, anesthesiology, cardiology, and endocrinology. It offers a diverse portfolio of pharmaceutical products, including chemical drugs, biologics, and injectables. The company is headquartered in Lianyungang, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
600276
Country
🇨🇳 China